BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 11179480)

  • 21. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
    Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
    Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
    Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
    Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
    Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
    Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Takeuchi T; Kitamura T
    Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].
    Yang JF; Chen SL; Liu ZH; Zhang Y
    Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
    Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
    Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
    Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER
    Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis.
    Park D; Kåresen R; Axcrona U; Noren T; Sauer T
    APMIS; 2007 Jan; 115(1):52-65. PubMed ID: 17223851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between cell-to-cell adhesion and angiogenesis and clinico-morphological prognostic factors in patients with gastric cancer.
    Bazas VM; Lukyanova NY; Demash DV; Galakhin KO; Myasoedov DV
    Exp Oncol; 2008 Sep; 30(3):235-9. PubMed ID: 18806748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
    Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer.
    Li YJ; Meng YX; Ji XR
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):471-7. PubMed ID: 14599963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
    Zhou YN; Li M
    Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
    Sommers CL; Gelmann EP; Kemler R; Cowin P; Byers SW
    Cancer Res; 1994 Jul; 54(13):3544-52. PubMed ID: 8012979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E-cadherin and catenins in early squamous cervical carcinoma.
    Van de Putte G; Kristensen GB; Baekelandt M; Lie AK; Holm R
    Gynecol Oncol; 2004 Aug; 94(2):521-7. PubMed ID: 15297198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
    Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
    Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of E-cadherin and alpha- and beta-catenins in thymoma.
    Pan CC; Ho DM; Chen WY; Chiang H; Fahn HJ; Wang LS
    J Pathol; 1998 Feb; 184(2):207-11. PubMed ID: 9602713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.